AFO Adjustments for Musculoskeletal Disorders (AFOHeel Trial)

"The primary metric monitored in this trial is the Centre of Pressure Velocity Magnitude (CPVM). Secondary outcomes include Activities-Specific Balance Confidence (ABC), PROMIS Patient Reported Outcomes for Physical Function, and Numerical Pain Rating Scale. The ABC survey evaluates balance confidence across everyday activities while PROMIS presents physical function through a computerized T-score system. Lastly, pain levels are assessed using an 11 point numerical scale with 0 being no pain and 10 being worst imaginable agony."

"Forty patients aged 18 to 70 with peripheral nervous system disorders may be eligible for this trial. To qualify, they must demonstrate the capacity to walk at least 50 feet without an aid and fit into traditional footwear, as well as meet GROUP 1 Inclusion criteria (e.g., having used their current AFO for more than two weeks and being able to move along slowly or moderately)."

"Information on clinicaltrials.gov attests that this trial is currently searching for suitable applicants, having been originally posted in November 2019 and revised as recently as January 12th 2022."

"The age requirement for this clinical trial is 18 to 70 years of age. There are an additional 39 studies offering their services to individuals below the established threshold and 314 investigations available for those beyond 65."

"Affirmative. Clinicaltrials.gov records refer to this clinical trial being actively recruiting, with the first post date of November 7th 2019 and last edit on January 12th 2022. The study requires 40 patients at a single site for participation."